South Korea · Delayed Price · Currency is KRW Cronex.Co.,Ltd Company Description
Cronex.Co.,Ltd engages in the research and development of medicines and raw materials for medical research.
The company offers contract research organization services for dental materials, various implant materials, bone marrow restorations, and bone regeneration, skin penetration, high-frequency therapy device, patch drug test, biological dressing material, wound dressing, franz diffusion test skin; spinal implant efficacy evaluation, bone defect bone graft material efficacy evaluation, cartilage regeneration efficacy evaluation, X-ray, micro-CT, and histology; drug effectiveness evaluation experiments for new drug development using minipigs, beagle dogs, and rabbits; preclinical efficacy evaluation using medium-sized animals; and test progress, animal management, animal anesthesia, post-test management of animals, sampling, and test evaluation services.
It also provides medical collagens and disease testing services; and engages in research on a transgenic pig model using gene editing technology and somatic cell nuclear transfer technology to overexpress foreign genes or remove existing genes.
The company was incorporated in 2012 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2012 |
| Industry | Commercial Physical and Biological Research |
| CEO | Young-Joon Son |
Contact Details
Address: JNK Digital Tower Seoul South Korea | |
| Phone | 82 70 5214 1998 |
| Website | cronex.co.kr |
Stock Details
| Ticker Symbol | 215570 |
| Exchange | Korea New Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Young-Joon Son | Chief Executive Officer |